Concord Healthcare Group Co., Ltd. (HKG:2453)

Market Cap	4.95B
Revenue (ttm)	413.22M
Net Income (ttm)	-471.67M
Shares Out	734.94M
EPS (ttm)	-0.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,283,200
Average Volume	21,837,505
Open	6.44
Previous Close	6.41
Day's Range	6.34 - 6.74
52-Week Range	5.25 - 52.20
Beta	n/a
RSI	58.10
Earnings Date	Aug 29, 2025

About Concord Healthcare Group

Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People’s Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company also offers oncology-related services, including sale and installation of medical equipment and software; management and technical support services to hospitals; and operating lease services. In addition, it engages in leasing of radiotherapy and diagnostic imaging equipm...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2008
• Employees: 567
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2453

Financial Performance

In 2024, Concord Healthcare Group's revenue was 388.31 million, a decrease of -27.91% compared to the previous year's 538.65 million. Losses were -443.22 million, 18.8% more than in 2023.

Financial numbers in CNY